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a b s t r a c t
Research has demonstrated the need for identifying a novel antimicrobial agent for topical use in the
pediatric dental population. The essential oil of Lippia sidoides Cham. (LSO) has been described as having
favorablebiologicalproperties, andabroad in vitroand in vivoantimicrobial spectrumagainstbacteria and
yeast infections. Our aimwas to determine a dose and formulation of LSO, acceptable for clinical testing in
apediatric populationwithdental caries. Thirty-seven6–12-yearold childrenwere selected toparticipate
in this study, and randomly allocated to receive different concentrations of either a gel (0.8%, 1%, 1.2% and
1.4%) or a mouth rinse (0.6%, 0.8%, 1% and 1.2%) formulation. The highest percentage MS reduction was
observed with 0.8% mouth rinse and 1.4% gel. The efﬁcacy of these concentrations was compared with
a Thy–Car mixture formulated as a mouth rinse and gel treatments in 11 children. Saliva was collected
after a single application of the antimicrobial treatment to establish effectiveness against MS. Both rinse
(p<0.001) and gel (p=0.02) formulations produced signiﬁcantMS reduction.Mouth rinse concentrations
above 0.8% were associated with a transient intra-oral burning sensation. In conclusion, mouth rinse and
gel LSO formulations demonstrated effectiveness against MS and good acceptance among children. We
suggest future randomized clinical trials to test its effectiveness against early childhood caries.ntroduction
During early childhood, dental caries tends to manifest an
ggressive nature, which usually differs from its expression in the
dult population. Therefore, the disease at this stage can rapidly
rogress to result in mass destruction of the primary dentition,
ompromising oral function and the child’s well-being (Den Besten
ndBerkowitz2003). Since, early contaminationwithMutans strep-
ococci (MS) is a major issue in this population (Köhler et al. 1988)
ith the potential for signiﬁcantly increasing caries risk, strate-
ies for treating this disease in children must focus on controlling
rowth of these pathogenic bacteria (Thibodeau and O’Sullivan
999). Under this understanding,many studies have attempted the
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identiﬁcation of an effective antimicrobial agent for the prevention
and treatment of early childhood caries (De Paola et al. 1977; Lobo
et al. 2008; Amin et al. 2004; Zhan et al. 2006); however, the search
for a novel and effective substance with favorable characteristics
such as safety, low cost and high effectiveness against MS remains
a challenge.
The essential oils of many different plants have been previously
tested in both in vitro and in vivo studies, as promising agents in
the treatment of oral diseases and other infections (Pai et al. 2004;
Fine et al. 1993; Nostro et al. 2007). Lippia sidoides Cham., a plant of
the verbenaceae family, popularly known as “Alecrim-Pimenta”, is
a bush with a brittle stem and odoriferous leaves, typically found in
the Northeast of Brazil. The chemical composition of Lippia sidoides
Cham. essential oil (LSO) has been previously described (Botelho
et al. 2007a,b; Fontenelle et al. 2007; Sousa et al. 2002). The oil
itself has proven signiﬁcant antifungal activity (Fontenelle et al.
Open access under the Elsevier OA license.2007), and broad antimicrobial action against many different bac-
teria (Lemos et al. 1990). The two major constituents of LSO are
thymol (50–59%) and carvacrol (7–16%) (Botelho et al. 2007a,b;
Fontenelle et al. 2007; Sousa et al. 2002). Phenolic compounds such
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Table 1
Constituents used in the different rinse and gel formulations of Lippia sidoides Cham.
essential oil (LSO). Volumes expressed for the highest rinse and gel concentrations.
1.2% LSO rinse 1.4% LSO gel
Hyetellose 1.20g
LSO 1.2ml 1.4ml
Polysorbate 80 8.00ml 4.44ml
Mentha Arvensis essence 0.10ml 0.10ml
Citric acid 0.60g 0.60g52 P.L.D. Lobo et al. / Phyto
s carvacrol and thymol have a proven wide spectrum of antimi-
robial action against yeasts and bacteria, being also constituents of
ther essential oils (Nostro et al. 2007). In spite of a limited number
f clinical studies demonstrating the antimicrobial efﬁcacy of LSO
n dental caries and periodontal disease (Ruoff et al. 2003; Silva
t al. 2005; Bertini et al. 2005), no previous work has investigated
ts effect in children with dental caries.
Thus, the purpose of this study was to verify dose–response
f different concentrations of rinse and gel formulations of LSO
ased on the effectiveness against MS in saliva, and to compare
heir efﬁcacy to theirmain isolated constituents (Thymol/Carvacrol
ixture), in order to establish safe use of this substance, its accep-
ance amongpediatric patients and aminimumeffective dosage for
uture clinical testing.
aterials and methods
xtraction and chemical analysis of LSO, thymol and carvacrol
Samples of Lippia sidoides Cham. were originally obtained from
he main garden of the Laboratory of Natural Products at UFC.
otanical identiﬁcation of the plant’s species was obtained at the
epartment of Biology. The collected leaves were dried under
hadow, ground, kept in vacuum-sealed plastic bags and identi-
ed for future use. The essential oil was extracted approximately 9
onths later by the steam distillation method in a Clevenger appa-
atus (Craveiro et al. 1976) and stored in glass containers, under
efrigeration until the moment to be used. Chemical constituents
ere identiﬁedbyspecialists at theDepartmentofChemistry, in the
ame university by using a gas chromatographer coupled to a mass
pectrometer system (GC–MS, Shimadzu, model QP 5050, Japan).
he main components of the Lippia sidoides Cham. essential oil
sed in thepresent studywere: cycloheptatriene, benzene,methyl-
oluene, cyclobutene, carvacrol and thymol. The Thymol/Carvacrol
ixture used for clinical testingwas isolated fromLSOby following
he same protocol and method used for extraction of the essential
il. The total content of the Thymol/Carvacrol mixture observed
y GC/MS was of 93.36%. Manipulation of the gel and mouth rinse
ormulations maintained an equivalent concentration of this mix-
ure, and a Thymol/Carvacrol ratio of 7:3, as previously described
y Gilbert et al. (2005).
tudy population
This study was approved by the Ethics Committee of the Federal
niversity of Ceará (UFC) Medical School, Brazil. After signature of
nformed consent by parents or legal guardians, forty-eight 6–12
ear-old children, from both genders, and having at least one cav-
tated or non cavitated (white spot lesions) carious surface were
nrolled to participate in this study from a population of 400 chil-
ren searching for dental care at the Pediatric Dental Clinic (UFC).
atient selectionwas carried out by one postgraduate student from
he same university. Children with a history of allergies or allergic
iseases, e.g. asthma, urticaria, rhinitis, sinusitis, or intraoral soft
issue lesions were excluded from the study. None of the partici-
ants underwent antibiotic treatment up to6months prior to study
nitiation, nor during the course of this clinical trial.
andomization and treatment application
All patients (N=48) were randomly allocated in one of 10 dif-
erent groups. Twenty twopatients received topical treatmentwith
outhwash formulationsof LSOatdifferent concentrations, and16
atients received LSO in gel formulations. Groups I (n=5), II (n=5),
II (n=6) and IV (n=5) received topical treatment with LSO rinse at
oncentrations of 0.6%, 0.8%, 1% and 1.2%, while groups V (n=4), VISodium saccharin 0.40g 0.40g
Puriﬁed water 89.70ml 91.86g
(n=4), VII (n=4) and VIII (n=4) received gel formulations at con-
centrations of 0.8%, 1%, 1.2% and 1.4%, respectively. Eleven children
received treatment with mouth rinse (n=6) or gel (n=5) formula-
tions of the Thymol/Carvacrol mixture (Thy–Car). Treatments were
formulated by the Laboratory of Pharmaceutical Science at the Fed-
eral University of Ceará, Fortaleza, Brazil (Table 1).
For topical application of the mouth wash formulations, chil-
dren were instructed to rinse with a volume of 5ml during 1min,
whereas each gel treatment was applied by placing 5ml of the gel
inside pre-fabricated trays, and applied once to the dentition dur-
ing 4min. Volumes were measured by using a graduated cylinder.
All treatments were applied in the dental ofﬁce, under supervi-
sion. Saliva was collected at two different moments, for instance,
prior to (T0) and following treatment application (T1). Immediately
after treatment session children were asked to report any discom-
forts experienced during treatment. Children’s acceptance of the
different formulations used in this study was assessed by personal
reports from children and their parents or legal guardians at the
time of treatment application. Thus, parents were instructed to
inform if staining, changes in taste or any other side-effects were
observed or reported by child within the ﬁrst 72h after treatment.
Saliva collection and microbiological analysis
For saliva collection patients were requested to chew on a
3×3 cm piece of Paraﬁlm® during 60 s in order to stimulate sali-
vary secretion and release plaque into the salivary ﬂuid. Saliva was
thencollectedwithadisposableplastic cannula andstored in sterile
ependorfs® for subsequent analysis. Samples were transported to
the laboratory for microbiological analysis in a hermetically sealed
case containing ice, and analyzed no longer than 2h after collection
(Ruoff et al. 2003).
A volume of 0.1ml of each sample was aseptically drawn and
transferred into one sterile test tube containing 0.9ml of saline.
Procedure was repeated twice, establishing dilutions of 1:10 and
1:100. A corresponding volume of 10l of each dilution was plated
onto Mitis Salivarius-Bacitracin (MSB) agar medium (Ruoff et al.
2003) in triplicates. The plates were then incubated at 37 ◦C, dur-
ing 48h, in jars under microaeroﬁlic conditions. Representative
colonies with morphological characteristics of MS were counted,
isolated and biochemically conﬁrmed to be MS utilizing mannitol,
sorbitol, lactose, rafﬁnose, melibiose and esculin. Bacterial counts
were expressed as colony forming units (CFU)/ml of saliva.
Statistical analysis
Results were expressed as reduction in the number of mutans
streptococci (MS) colony forming units (CFU) before (T0) and after
treatment (T1) application. Percentage MS reduction was calcu-
lated based on the following formula: % MS= [MS T0−MS T1]/MS
T0×100). For comparisons between the different LSO concentra-
tions of the two formulations Analysis of Variance (ANOVA) was
used. Tukey test was applied for multiple comparisons to ver-
ify differences between concentrations. Comparisons between gel
P.L.D. Lobo et al. / Phytomedicine 18 (2011) 551–556 553
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Fig. 2. Dose–response curve of Lippia sidoides Cham. essential oil gel (n=16).
signiﬁcance was observed (1138.00±987.20 vs. 641.33±664.00,
p=0.0531) (Table 3).
Table 2
Mutans streptococci colony forming units expressed in the mean (±standard devi-
ation) percentage CFU reduction of the groups treated with mouth rinses and gels
of Lippia sidoides Cham. essential oil and Thymol/Carvacrol mixture.
0.8% LSO rinse Thy–Car rinse p-Value
Mean SDM Mean SDM
77.69 21.48 54.15 17.53 0.0758ig. 1. Dose–response curve of Lippia sidoides Cham. essential oil mouth rinse
n=21). Response corresponds to the mean± standard deviation of the relative
ercentage reduction in mutans streptococci colony forming units (CFU).
nd mouth rinse formulations before (T0) and after (T1) treatment
pplicationweremade using Student’s t test for unpaired variables.
or each gel and mouth rinse concentration comparisons between
0andT1wasmadebyapplyingStudent’s t test forpairedvariables.
esults
No side-effects were described by children or parents following
opical application of LSO in the forms of eithermouth rinse at 0.6%,
r at any given gel concentration. According to children and par-
nts,mouth rinse concentrations above0.8%were associatedwith a
ransient intra-oral burning sensation. However, no damage to the
ntra-oral tissues was observed. Patients manifested good accep-
ance for both formulations at different concentrations in regard to
aste and smell. No other speciﬁc complaints were reported.
omparisons between different concentrations of LSO
Comparisons between different concentrations of the mouth
inse formulations showed no statistically signiﬁcant differences
n percentage MS reduction (F=0.24, p=0.86). However, plotting
f a dose–response curve for the various mouth rinse concen-
rations showed the highest percentage MS reduction with LSO
outh rinse at the concentration of 0.8% (Fig. 1). Similarly, no sta-
istical difference in percentage MS reduction was observed when
omparing the various gel concentrations (F=1.43, p=0.28). Plot-
ing of a dose–response curve for the different gel concentrations
emonstrated the highest percentage MS reduction with 1.4% LSO
el (Fig. 2). When comparing equal concentrations of the gel and
inse formulationsno statistical signiﬁcantdifferencewasobserved
etween groups, for instance 0.8% (77.69±21.48 vs. 39.72±47.48,
= 0.15), 1% (72.35±25.24 vs. 40.34±38.19, p=0.14) and 1.2%
62.77±29.29 vs. 52.37±28.79, p=0.61).
omparisons between treatments
In order to measure the efﬁcacy of LSO in comparison with the
hy–Car group, comparisons were made between the latter and
he most effective LSO mouth rinse and gel formulations, under-
tood as the treatments that expressed the highest percentage
S reduction within a dose–response curve. No statistical differ-
nces were observed when comparing 0.8% LSO (77.69±21.48%)
s. Thy–Car (54.15±17.53%) mouth rinses (p=0.0758), and 1.4%
SO (83.05±8.95%) vs. Thy–Car (56.75±26.56%, p=0.1030) gel
reatments (Table 2). Comparisons of mean MS levels in T0 (0.8%
SO, 3005±2868.78 vs. Thy–Car, 1455.55±1214.54 p=0.2574)
nd T1 (0.8% LSO, 537.66±504.41 vs. Thy–Car, 720.55±704.18,Response corresponds to the mean± standard deviation of the relative percentage
reduction in mutans streptococci colony forming units (CFU).
p=0.6396) between 0.8% LSO and Thy–Car rinses did not differ sta-
tistically. Similar results were observed when comparing MS levels
in T0 (3673.74±3745.50 vs. 1137.66±987.198, p=0.1837) and T1
(445.41±402.84 vs. 641.33±663.87, p=0.6223) between 1.4% LSO
andThy–Cargel formulations, respectively. Thepercentageeffect of
MS reduction generated by the Thy–Car treatments was equivalent
to 95.53%±25.33% of the total LSO effect against MS.
Comparisons before and after treatment
Comparisons of percentage MS reduction between T0 and T1
among different mouth rinse concentrations showed a statistical
signiﬁcant decrease at 0.6% (3012±1792 vs. 446±388, p=0.049)
and 1% (1349±909.9 vs. 518.6±723.5, p=0.006) concentrations,
but no signiﬁcant reduction was observed with 0.8% (3005±2869
vs. 537.7±504.4, p=0.13) or 1.2% (3967±2393 vs. 976±580.4,
p=0.0768) LSO mouth rinses. However, within the gel groups no
signiﬁcant reduction was observed when comparing percentage
MS reduction between T0 and T1 (Table 3).
When comparing percentage MS reduction in T0 and T1 within
the two different treatment formulations (gel and mouth rinse),
regardless of the concentration used, a signiﬁcant reduction was
veriﬁed within both groups (Table 4), with no statistical differ-
ence in percentage MS reduction being observed between these
two groups (70.35±27.09% vs. 53.87±35.41%, p=0.1174).
Comparisons between T0 and T1within the Thy–Car rinse group
demonstrated a signiﬁcant post-treatment reduction in the mean
MS levels (1455.60±1214.54 vs. 720.60±704.20, p=0.0275). In
addition, a trend in MS reduction was observed when comparing
T0 and T1 within the Thy–Car gel group, although no statistical1.4% LSO gel Thy–Car gel p-Value
Mean SDM Mean SDM
83.05 8.95 56.75 26.56 0.1030
554 P.L.D. Lobo et al. / Phytomedic
Table 3
Mutans streptococci colony forming units in saliva (mean± standard deviation),
before and after treatmentwith different concentrations of rinse or gel formulations
of Lippia sidoides Cham. essential oil (LSO) and Thymol/Carvacrolmixture (Thy–Car).
Formulations Pre-treatment Post-treatment p-Value†
Mean SDMa Mean SDMa
Mouth rinse
0.6% LSO 3012.00 1792.00 446.00 388.00 0.049
0.8% LSO 3005.00 2869.00 537.70 504.40 0.13
1.0% LSO 1349.00 909.90 518.60 723.50 0.006
1.2% LSO 3967.00 2393.00 976.00 580.40 0.07
Thy–Car 1455.60 1214.54 720.60 704.20 0.0275‡
Gel
0.8% LSO 1083.33 877.63 585.00 468.52 0.17
1.0% LSO 1148.12 384.20 785.83 678.14 0.10
1.2% LSO 1640.41 2042.71 377.49 214.98 0.26
1.4% LSO 3673.74 3745.50 445.41 402.84 0.14
Thy–Car 1138.00 987.20 641.33 664.00 0.0531
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† Paired t test used for comparisons.
‡ Statistical signiﬁcance, post-treatment <pre-treatment.
iscussion
The present study was designed with the main objective of
stablishing a parameter of LSO dosage and formulation for future
esting in a clinical setting. The use of LSO was based on previous
ork by Nunes et al. (2006) that has standardized Lippia sidoides
aw material and its vegetal extract, and has determined its in vitro
ntimicrobial activity against Streptococcus mutans. The authors
oncluded that Lippia sidoides raw material and extract contained
olatile constituents, which in plants are related to an intrinsic
iological action, and thus could be employed in the production
f clinical formulations for dental use. In 1990, Lemos et al. ana-
yzed theantimicrobial actionofdifferent essential oils, andveriﬁed
ctivity of LSO against E. Coli, S. aureus, P. aeruginosa, B. subtilis and
. smegmatis. Limited antimicrobial activity was observed against
ramnegativebacteria, suchasP. aeruginosaandE. coli. A later study
f the antibacterial effect of essential oils of plants from the North-
ast of Brazil, demonstrated sensitivity of S. aureus and E. coli to
SO; however, P. aeruginosa showed resistance to the action of this
ssential oil (Bertini et al. 2005). These results have conﬁrmed LSO
shavingmainlyagrampositiveantibacterial spectrum, inaddition
o a limited action against gram negative bacteria. However, to our
nowledge, only two clinical trials testing the effectiveness of LSO
ormulations have been reported in the literature and none have
ested LSO in a gel formulation. In addition, this study is the ﬁrst to
rovide clinical data on the efﬁcacy of LSO in reducing salivary MS
n children with dental caries.
Chlorhexidine remains the gold standard in the inhibition of
ental bioﬁlm formation (Matthijs and Adriacns 2002). It has been
emonstrated that clinical application of chlorhexidine within the
ral cavity, in the form of gel or rinses, is effective in reducing MS in
oth saliva and dental plaque (Twetman and Petersson 1997). This
able 4
utans streptococci colony forming units in saliva (mean± standard deviation),
efore and after treatment with rinse or gel formulations of Lippia sidoides Cham.
ssential oil.
Formulations Pre-treatment Post-treatment p-Value†
Mean SDMa Mean SDMa
Rinse (n=21) 2762.53 2152.27 614.76 568.53 <0.001
Gel (n=16) 1886.40 2238.13 548.43 451.20 0.02
p-Value‡ 0.23 0.70
a Standard deviation of the mean.
† Paired t test used for comparisons within groups.
‡ Unpaired t test used for comparisons between groups.ine 18 (2011) 551–556
actioncanbeattributed to its substantivity combinedwith its speci-
ﬁcity against oral pathogens, thus being one of the most frequently
prescribed topical antimicrobials in dentistry (Kidd 1991; Law and
Seow 2007). However, unpleasant taste, tooth staining after long
term use and the need for frequent applications has stimulated the
search for new and more appropriate alternatives for use in young
children (Addy et al. 1991). Previous studies have established the
ability of antibiotics in temporarily reducing MS from the oral cav-
ity, (De Paola et al. 1974; Loesche et al. 1977; Jacobson et al. 1990)
in order to initiate an ecological shift in the cariogenic bioﬁlm. This
objectivewould be better attainedwith a narrow spectrum antimi-
crobial agent, activeagainst Streptococcus species, presentinga low
allergenic potential and poor absorption through the gastrointesti-
nal tract. The search for a substancewith such speciﬁc and favorable
properties led to in vivo testing of vancomycin, and a reduction in
plaque MS was observed (De Paola et al. 1974, 1977; Jordan and De
Paola 1974, 1977).
Wehave previously compared the efﬁcacy of gel formulations of
vancomycin and chlorhexidine in the reduction of MS in the saliva
of children with dental caries (Lobo 2007). A 1% chlorhexidine gel
demonstrated efﬁcacy in MS reduction after 6 consecutive days of
topical application, once a day, during 10min. A 3% vancomycin gel
was equally effective in reducing salivary MS, by using the same
application regimen. In addition, a 1.23% sodiumﬂuoride gel lacked
the ability to reduce MS in saliva (Lobo et al. 2008). In the present
study, comparable results in MS reduction were observed with the
use of Lippia sidoides Cham. essential oil. However, both chlorhex-
idine and vancomycin treatments generated a drastic decrease in
salivary MS levels, in comparison to the reductions observed fol-
lowing topical treatment with LSO. Since great reductions tend to
be followedbya signiﬁcant increase in salivaryMS levels 2–4weeks
after treatment application (Lobo et al. 2008), we believe that less
abrupt but sustainable reductions in MS levels may be more favor-
able for reducing caries risk in children, and a change in bacterial
pathogenicity may outweigh the importance of bacterial counts for
this purpose.
Natural products, such as LSO, have received increased atten-
tiondue to their diverse rangeof biological properties, representing
sources for the discovery of novel bioactive compounds (Carvalho
et al. 2003; Costa et al. 2001). In addition, studies conducted
with the main constituents of the Lippia sidoides Cham. essential
oil, thymol carvacrol, have demonstrated an excellent antimicro-
bial activity of these compounds against pathogens involved in
the dental caries process (Botelho et al. 2007a,b; Nostro et al.
2007). Recently, Botelho et al. (2007a,b) made a comparative study
of the in vitro antimicrobial action of LSO, and its major con-
stituents (thymol and carvacrol) against Streptococcus mutans, S.
mitis, S. salivarius and S. sanguis. Their results demonstrated a
strong antibacterial action of LSO, thymol and carvacrol against
these bacteria; however, the phenolic monoterpenes inhibited
bacterial growth at signiﬁcantly lower concentrations. The major
constituents of LSO are thymol (50–59%), carvacrol (7–16%), -
cymene (6–9%) and eucalyptol (2–10%) (Botelho et al. 2007a,b;
Fontenelle et al. 2007; Sousa et al. 2002). While eucalyptol is com-
monlyusedbypharmaceutical industries to impartﬂavor tovarious
medicines, phenolic compounds such as carvacrol and thymol have
a proven wide spectrum of antimicrobial action against yeasts and
bacteria, being also constituents of other essential oils (Nostro et al.
2007). In agreement with these ﬁndings, our results have demon-
strated the ability of a mouth rinse containing a Thymol/Carvacrol
mixture to signiﬁcantly reduce MS in the saliva of children with
dental caries, whereas a gel formulation demonstrated a trend
towards a reduction in salivary MS levels following treatment. This
level of reductionwas not observedwith 0.8% or 1.4% Lippia sidoides
Cham. essential oil formulated asmouth rinse or gel, respectively. A
synergistic effect between carvacrol and thymol (Didry et al. 1993,
medic
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994) has been previously described. In addition, an antagonism
etween LSO minor components (specially -cymene), thymol and
arvacrol (Bassole et al. 2003) may partly explain the lack of sig-
iﬁcance in the MS reduction produced following treatment with
ifferent formulations and concentrations of this essential oil. In
pite of these differences, comparisons between groups failed to
emonstrate a greater efﬁcacy of the Thy–Car mixture over 0.8%
SO rinse and 1.4% gel treatments.
Presently, mouth rinse formulations at the concentrations of
.6% and 1% had the ability to signiﬁcantly reduce MS following
reatment, while the concentration of 0.8% in a dose–response
urve demonstrated the highest percentage MS reduction and was
ell accepted by all patients. The establishment of safety and ade-
uatedosages for clinical testingwas currently basedon the limited
umber of reports testing this substance in adult patients. Pre-
iously, Fernandes Filho et al. (1998) have tested an LSO mouth
inse at a concentration of 0.6%. Twenty patients, with a mean
ge of 18 years participated in this clinical trial. Ten participants
ere treated with a 0.6% LSO rinse, while the other 10 participants
eceived placebo. Treatment had 1-weekduration, andparticipants
nderwent daily evaluation of dental plaque and gingival bleeding
ndexes during this period. Subjects were instructed not to brush
heir teeth nor use other oral hygiene methods beside the rinse.
he authors veriﬁed that the 0.6% LSO rinse reduced gingival bleed-
ng and caused a 6% reduction in dental plaque index, whereas in
he placebo group a 12% increase in plaque index was observed
ssociated with no improvement in gingival bleeding.
Later, the efﬁcacy of a 1% LSO mouth rinse formulation was
ested in 55 adults, with ages between 17 and 63 years. A 0.12%
hlorhexidine rinse was used as a positive control. Patients rinsed
wice a day, during 7 consecutive days. Dental plaque and gin-
ival bleeding indexes did not differ between groups. However,
he 1% LSO mouth rinse concentration caused a moderate burn-
ng sensation in 44% of patients. In addition, one patient reported
ausea, and epithelial desquamation was described by 2 partici-
ants (Bertini et al. 2005). In the present study, LSO mouth rinse
oncentrations above 0.8% were associated with burning sensation
f the intra-oral soft tissues, possibly due to a direct contact of the
inse with the mucosa, gingiva and tongue. In contrast, application
f the gel inside trays minimized soft tissue contact, not allow-
ng this side-effect to be expressive. A superior performance in
ercentage MS reduction of the 1.4% LSO gel was observed in a
ose–response curve, when compared to lower concentrations of
he same formulation. Although no superior action of individual
SOgel concentrationswasobservedwhencompared to thevarious
outh rinse formulations, comparisons between all gel and mouth
inse formulations, regardless of the concentrations used, showed
ubstantial percentage MS reduction after treatment application.
hus, testing of higher LSO dosages can be carried out as gels, as
ong as applied in trays, but the use of mouth rinse formulations
ith concentrations above 0.8% should be avoided.
In summary, LSO rinses and gel formulations were effective in
educing MS, and equally safe for future testing in a larger clin-
cal setting. A thymol–carvacrol mixture was highly effective in
educing MS in saliva, but its efﬁcacy was not superior to the
SO mouth rinse and gel formulations with the highest percent-
ge MS reductions, demonstrating a close association between the
ntimicrobial efﬁcacy of this essential oil and the action of its main
onstituents. Further studies are needed to test the efﬁcacy of thy-
ol and carvacrol alone or in association, since their safety has
een established. Carvacrol and thymol are components of innu-
erous aromatic plants. While thymol is available for clinical usegainst dental caries in association with chlorhexidine and other
ubstances in the US, Carvacrol is currently approved by the FDA
or food use, having also been included by the Council of Europe
n the list of chemical ﬂavorings (De Vincenzi et al. 2004). Differ-ine 18 (2011) 551–556 555
ent gel and mouth rinse concentrations of Lippia sidoides Cham.
essential oil are effective in reducing MS in saliva, with minor side-
effects, demonstrating good acceptance among children. The most
adequate concentrations of Lippia sidoides Cham. essential oil for
in vivo testing inboth rinseandgel formulationswere0.8%and1.4%,
respectively. LSO is an essential oil potentially effective against MS
that warrants future clinical studies to verify its efﬁcacy against
early childhood caries.
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